Study Review - Abatacept vs upadacitinib for rheumatoid arthritis

As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of the Select-Choice trial looking at Abatacept vs Upadacitinib for treatment of rheumatoid arthritis.

Independent expert commentary is provided by Associate Professor Les Barnsley, Senior Staff Specialist and Head in the Department of Rheumatology at Concord Hospital and Associate Professor in the Department of Medicine at the University of Sydney.

Please login below to download this issue (PDF)

Subscribe